期刊文献+

Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival 被引量:10

Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival
下载PDF
导出
摘要 AIM: To investigate whether TL-10-transduced dendritic cells (DCs) could induce tolerogenicity and prolong allograft survival in rat intestinal transplantation.METHODS: Spleen-derived DCs were prepared and genetically modified by hTL-10 gene. The level of IL-10 expression was quantitated by ELTSA. DC function was assessed by MTT in mixed leukocyte reaction. Allogeneic T-cell apoptosis was examined by flow cytometric analysis. Seven days before heterotopic intestinal transplantation, 2x106 donor-derived IL-10-DC were injected intravenously, then transplantation was performed between SD donor and Wistar recipient.RESULTS: Compared with untransduced DC, IL-10-DC could suppress allogeneic mixed leukocyte reaction (MLR). The inhibitory effect was the most striking with the stimulator/effector (S/F) ratio of 1:10. The inhibition rate was 33.25 %,41.19 % (P<0.01) and 22.92 % with the S/E ratio of 1:1,1:10 and 1:50 respectively. At 48 hours and 72 hours by flow cytometry counting, apoptotic T cells responded to IL-10-DC in MLR were 13.8 % and 30.1%, while untransduced group did not undergo significant apoptosis (P<0.05). IL-10-DC pretreated recipients had a moderate survival prolongation with a mean allograft survival of 19.8 days (P<0.01),compared with 7.3±2.4 days in control group and 8.3±2.9days in untransduced DC group. Rejection occurred in the control group within three days. The difference between untreated DC group and control group was not significant.CONCLUSION: IL-10-DC can induce allogenic T-cell hyporesponsiveness in vitro and apoptosis may be involved in it. IL-10-DC pretreatment can prolong intestinal allograft survival in the recipient. AIM:To investigate whether IL-10-transduced dendritic cells (DCs) could induce tolerogenicity and prolong allograft survival in rat intestinal transplantation. METHODS:Spleen-derived DCs were prepared and genetically modified by hIL-10 gene.The level of IL-10 expression was quantitated by ELISA.DC function was assessed by MTT in mixed leukocyte reaction.Allogeneic T-cell apoptosis was examined by flow cytometric analysis.Seven days before heterotopic intestinal transplantation,2×10~6 donor-derived IL-10-DC were injected intravenously,then transplantation was performed between SD donor and Wistar recipient. RESULTS:Compared with untransduced DC,IL-10-DC could suppress allogeneic mixed leukocyte reaction (MLR).The inhibitory effect was the most striking with the stimulator/ effector (S/E) ratio of 1:10.The inhibition rate was 33.25 %, 41.19 % (P<0.01) and 22.92 % with the S/E ratio of 1:1, 1:10 and 1:50 respectively.At 48 hours and 72 hours by flow cytometry counting,apoptotic T cells responded to IL- 10-DC in MLR were 13.8 % and 30.1%,while untransduced group did not undergo significant apoptosis (P<0.05).IL-10- DC pretreated recipients had a moderate survival prolongation with a mean allograft survival of 19.8 days (P<0.01), compared with 7.3±2.4 days in control group and 8.3±2.9 days in untransduced DC group.Rejection occurred in the control group within three days.The difference between untreated DC group and control group was not significant. CONCLUSION:IL-10-DC can induce allogenic T-cell hyporesponsiveness in vitro and apoptosis may be involved in it.IL-10-DC pretreatment can prolong intestinal allograft survival in the recipient.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第11期2509-2512,共4页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献34

  • 1[1]Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296 被引量:1
  • 2[2]Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 1999;68:1-8 被引量:1
  • 3[3]Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex [MHCJ class Ⅱ molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185:541-550 被引量:1
  • 4[4]Takayama T, Kaneko K, Morelli AE, Li W, Tahara H, Thomson AW. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation 2002; 74:112-119 被引量:1
  • 5[5]Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998; 66:1567-1574 被引量:1
  • 6[6]Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971;70:693-702 被引量:1
  • 7[7]Grover R, Lear PA, Ingham Clark CL, Pockley AG, Wood RF.Method for diagnosing rejection in small bowel transplantation.Br J Surg 1993; 80:1024-1026 被引量:1
  • 8[8]Tzakis AG, Thompson JF. Current status of diagnosis of small bowel rejection. Pediatr Transplant 1998; 2:87-88 被引量:1
  • 9[9]Sher LS. Immunosuppression. Curr Opin Organ Transplant 2001;6:311 被引量:1
  • 10[10]Ghanekar A, Grant D. Small bowel transplantation. Curr Opin Crit Care 2001; 7:133-137 被引量:1

同被引文献53

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部